Foresite Capital Management IV’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-156,355
| Closed | -$5.32M | – | 18 |
|
|
2020
Q1 | $5.32M | Buy |
+156,355
| New | +$5.32M | 6.56% | 5 |
|
|
2019
Q4 | – | Sell |
-425,794
| Closed | -$17.8M | – | 19 |
|
|
2019
Q3 | $17.8M | Sell |
425,794
-3,896
| -0.9% | -$163K | 5.74% | 7 |
|
|
2019
Q2 | $18.8M | Sell |
429,690
-88,870
| -17% | -$3.89M | 5.32% | 6 |
|
|
2019
Q1 | $26.7M | Sell |
518,560
-337,340
| -39% | -$17.4M | 9.59% | 4 |
|
|
2018
Q4 | $31.7M | Buy |
855,900
+4,700
| +0.6% | +$174K | 14.53% | 1 |
|
|
2018
Q3 | $32M | Hold |
851,200
| – | – | 10.48% | 3 |
|
|
2018
Q2 | $33.6M | Hold |
851,200
| – | – | 11.47% | 2 |
|
|
2018
Q1 | $21.9M | Buy |
851,200
+637,765
| +299% | +$16.4M | 9.09% | 4 |
|
|
2017
Q4 | $5.76M | Buy |
+213,435
| New | +$5.76M | 4.04% | 9 |
|